Biomedical Engineering Reference
In-Depth Information
388. Zelcer N, Huisman MT, Reid G, Wielinga P, Breedveld P, Kuil A, Knipscher P, Schellens
JHM, Schinkel AH, Borst P. 2003. Evidence for two interacting ligand binding sites
in human multidrug resistance protein 2 (ATP binding cassette C2). J Biol Chem 278:
23538-23544.
389. Dombrowski F, Kubitz R, Chittattu A, Wettstein M, Saha N, Haussinger D. 2000. Electron-
microscopic demonstration of multidrug resistance protein 2 (Mrp2) retrieval from the
canalicular membrane in response to hyperosmolarity and lipopolysaccharide. Biochem
J 348 (Pt 1): 183-188.
390. Kipp H, Arias IM. 2000. Intracellular trafficking and regulation of canalicular ATP-
binding cassette transporters. Semin Liver Dis 20: 339-351.
391. Kauffmann HM, Keppler D, Kartenbeck J, Schrenk D. 1997. Induction of cMrp/cMoat
gene expression by cisplatin, 2-acetylaminofluorene, or cycloheximide in rat heptocytes.
Hepatology 26: 980-985.
392. Kauffmann HM, Keppler D, Gant TW, Schrenk D. 1998. Induction of hepatic mrp2
(cmrp/cmoat) gene expression in nonhuman primates treated with rifampicin or tamox-
ifen. Arch Toxicol 72: 763-768.
393. Courtois A, Payen L, Guillouzo A, Fardel O. 1999. Up-regulation of multidrug resistance-
associated protein 2 (MRP2) expression in rat hepatocytes by dexamethasone. FEBS Lett
459: 381-385.
394. Courtois A, Payen L, Le Ferrec E, Scheffer GL, Trinquart Y, Guillouzo A, Fardel O.
2002. Differential regulation of multidrug-resistance associated protein 2 (MRP2) and
cytochromes P450 2B1/2 and 3A1/2 in phenobarbital-treated hepatocytes. Biochem Phar-
macol 63: 333-341.
395. Kubitz R, Warskulat U, Schmitt M, Haussinger D. 1999. Dexamethasone- and osmolarity-
dependent expression of the multidrug-resistance protein 2 in cultured rat hepatocytes.
Biochem J 340: 585-591.
396. Payen L, Sparfel L, Courtois A, Vernhet L, Guillouzo A, Fardel O. 2002. The drug
efflux pump MRP2: regulation of expression in physiopathological situations and by
endogenous and exogenous compounds. Cell Biol Toxicol 18: 221-233.
397. Kast HR, Goodwin B, Tarr PT, Jones SA, Anisfeld AM, Stoltz CM, Tontonoz P, Kliewer
S, Willson TM, Edwards PA. 2002. Regulation of multidrug resistance-associated protein
2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor,
and constitutive androstane receptor. J Biol Chem 277: 2908-2915.
398. Vernhet L, Seite MP, Allain N, Guillouzo A, Fardel O. 2001. Arsenic inducers expression
of the multidrug resistance-associated protein 2 (MRP2) gene in primary rat and human
hapatocytes. J Pharmacol Exp Ther 298: 234-239.
399. Schrenk D, Baus PR, Ermel N, Klein C, Vorderstemann B, Kauffmann HM. 2001. Up-
regulation of transporters of the MRP family by drugs and toxins. Toxicol Lett 120: 51-57.
400. Shibayama Y, Ikeda R, Motoya T, Yamada K. 2004. St. John's wort (hypericum
perforatum) induces overexpression of multidrug resistance protein 2 (MRP2) in rats: a
30-days ingestion study. Food Chem Toxicol 42: 995-1002.
401. Demeule M, Jodoin J, Beaulieu E, Brossard M, Beliveau. 1999. Dexamethasone
modulation of multidrug transporters in normal tissues. FEBS Lett 442: 208-214.
402. Gerk PM, Vore M. 2002. Regulation of expression of the multidrug resistance-associated
protein 2 (MRP2) and its role in drug disposition. J Pharmacol Exp Ther 302: 407-
415.
Search WWH ::
Custom Search